Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

40 results about "Adventitia" patented technology

The adventitia, (advɛnˈtɪʃə) is the outer layer of fibrous connective tissue surrounding an organ. The outer layer of connective tissue that surrounds an artery, or vein – the tunica externa, is also called the tunica adventitia.

Electrical energy ablation systems, devices and methods for the treatment of tissue

ActiveUS12329439B1EndoscopesMedical devicesSurgeryDuodenal mucous membrane
A device for ablating target tissue of a patient with electrical energy is provided. An elongate shaft includes a proximal portion and a distal portion, and a radially expandable element is attached to the distal portion. An ablation element for delivering electrical energy to target tissue is mounted to the radially expandable element. The device can be constructed and arranged to ablate the duodenal mucosa of a patient while avoiding damage to the duodenal adventitial tissue. Systems and methods of treating target tissue are also provided.
Owner:FRACTYL HEALTH INC

Electrical energy ablation systems, devices and methods for the treatment of tissue

ActiveUS20250312084A1EndoscopesMedical devicesSurgeryDuodenal mucous membrane
A device for ablating target tissue of a patient with electrical energy is provided. An elongate shaft includes a proximal portion and a distal portion, and a radially expandable element is attached to the distal portion. An ablation element for delivering electrical energy to target tissue is mounted to the radially expandable element. The device can be constructed and arranged to ablate the duodenal mucosa of a patient while avoiding damage to the duodenal adventitial tissue. Systems and methods of treating target tissue are also provided.
Owner:FRACTYL HEALTH INC

Apparatus for effective ablation and nerve sensing associated with denervation

An intravascular catheter for nerve activity ablation and / or sensing includes one or more needles advanced through supported guide tubes (needle guiding elements) which expand to contact the interior surface of the wall of the renal artery or other vessel of a human body allowing the needles to be advanced though the vessel wall into the extra-luminal tissue including the media, adventitia and periadvential space. The catheter also includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened needles are advanced to penetrate into the vessel wall. Electrodes at the distal ends of the guide tubes allow sensing of nerve activity before and after attempted renal denervation. In a combination embodiment ablative energy or fluid is delivered to ablate nerves outside of the media.
Owner:ABLATIVE SOLUTIONS INC

Method for denervation with reduced pain

An intravascular catheter for nerve activity ablation and / or sensing includes one or more needles advanced through supported guide tubes (needle guiding elements) which expand to contact the interior surface of the wall of the renal artery or other vessel of a human body allowing the needles to be advanced though the vessel wall into the extra-luminal tissue including the media, adventitia and periadvential space. The catheter also includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened needles are advanced to penetrate into the vessel wall. Electrodes at the distal ends of the guide tubes allow sensing of nerve activity before and after attempted renal denervation. In a combination embodiment ablative energy or fluid is delivered to ablate nerves outside of the media.
Owner:ABLATIVE SOLUTIONS INC

Nerve repair fixing sleeve

The invention relates to the technical field of medical apparatus and instruments, and discloses a nerve repair fixing cannula, a flexible connection sheet can be bent into a tubular shape, so that two ends of the flexible connection sheet respectively wrap the peripheries of two nerve broken ends, the inner side of the flexible connection sheet is provided with a growth space, a tubular structure for nerve bridging is established, nerve axons grow directionally, and the two nerve broken ends are kept aligned; the multiple microneedles are arranged at the two ends of the flexible connecting piece at intervals, the connecting tension of the nerve bundle layer and the flexible connecting piece is dispersed, and the pain feeling of a patient is relieved; a needle head of the microneedle is used for being inserted into an adventitia so as to fix the bent flexible connecting piece to the nerve broken end, a needle rod penetrates through the flexible connecting piece, and the needle rod and the outer tangent plane of the bent flexible connecting piece at the needle threading position are obliquely arranged at a first preset angle, so that the mechanical stability of the nerve repair fixing sleeve installed on the nerve broken end is improved; the nerve broken end can be quickly and conveniently fixed, meanwhile, the damage to nerve tracts is reduced, and the situation that the nerve function recovery is affected by scars is avoided.
Owner:HUA RONG KE CHUANG BIOTECHNOLOGY(TIAN JIN) CO LTD

Construction method and application of animal model for cardiomyopathy induced by circulating system

The invention relates to the technical field of medical animal model construction, in particular to a construction method and application of a cardiomyopathy animal model induced by a circulating system. According to the invention, the Abeta25-35 is injected into the adventitia, so that the animal model of the cardiomyopathy induced by the Abeta25-35 through the tissue fluid circulatory system of the adventitia is constructed in the SD rat for the first time. In the model, A beta 25-35 is subjected to myocardial perfusion through lower limb vascular adventitia to induce myocardial diffuse fibrosis and ejection fraction reduction of SD rats, which are in accordance with epidemiological research data. The model can be used for subsequently researching the pathogenic mechanism of A beta25-35 induced cardiomyopathy and a novel treatment method taking vascular adventitia tissue fluid transmission as a way, and also provides a brand new view angle for researching the pathogenic mechanism of AD or cerebrovascular diseases and a diagnosis and treatment method.
Owner:BEIJING HOSPITAL

Ablation systems, devices and methods for the treatment of tissue

A device for ablating target tissue of a patient with an ablative fluid is provided. An elongate shaft includes a proximal portion and a distal portion, and at least one fluid delivery element is attached to the distal portion. The device can be configured to ablate the duodenal mucosa of a patient while avoiding damage to the duodenal adventitial tissue. Systems and methods of treating target tissue are also provided.
Owner:FRACTYL HEALTH INC

Tissue separation pad beneficial to microvascular anastomosis

ActiveCN223845694UDiagnosticsSurgeryVascular anastomosisVASCULAR EMBOLISM
The utility model discloses a tissue separation pad beneficial to microvascular anastomosis, which comprises a pad, an air cushion is arranged on the inner wall of the pad, a support is arranged in the air cushion, two suture pads are arranged above the pad, and the two suture pads can be attached to each other. The utility model relates to the technical field of vascular anastomosis, in particular to a tissue separation pad beneficial to microvascular anastomosis, which can play a role in physically separating tissues around a blood vessel from a lumen of the blood vessel through the matching of a gasket, an air cushion, a winding rope, a titanium alloy layer and a bracket, and provides a relatively pure anastomosis environment. In the process, some easily-coagulated substances, fat particles, vascular adventitia and other tissues are effectively prevented from entering a vascular lumen in the anastomosis process, vascular embolism is prevented, and the tissue separation pad beneficial to microvascular anastomosis can be expanded outwards all the time by means of the elasticity of the support, so that the tissue separation pad is more stable. And the phenomenon of vascular occlusion caused by extrusion of the tissue separation pad beneficial to microvascular anastomosis is avoided.
Owner:HANGZHOU PLASTIC SURGERY HOSPITAL CO LTD

Gynecological vaginal dilator

The vaginal dilator comprises a lantern-shaped dilation assembly and an adjusting assembly, the lantern-shaped dilation assembly comprises a first connecting ring, a second connecting ring, a deformable connecting framework and a transparent outer film, and the first connecting ring and the second connecting ring are parallel and coaxial; one end of the deformable connecting framework is connected with the first connecting ring, the other end of the deformable connecting framework is connected with the second connecting ring, the transparent outer film wraps the deformable connecting framework, one end of the transparent outer film is connected with the first connecting ring, the other end of the transparent outer film is connected with the second connecting ring, and the adjusting assemblies are evenly distributed between the first connecting ring and the second connecting ring in the circumferential direction. According to the vaginal dilator for the gynecology department, overall circumferential dilation can be achieved, the cervix uteri is fully exposed so that observation can be facilitated, the contact area between the vaginal dilator and the vaginal wall is larger, discomfort of a patient in the examination process can be relieved, psychological burdens can be relieved, and the vaginal dilator is further provided with a convenient channel for liquid medicine injection so that immediate treatment after examination can be facilitated.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

Electrical energy ablation systems, devices and methods for the treatment of tissue

ActiveUS20250177031A1EndoscopesMedical devicesDuodenal mucous membraneTarget tissue
A device for ablating target tissue of a patient with electrical energy is provided. An elongate shaft includes a proximal portion and a distal portion, and a radially expandable element is attached to the distal portion. An ablation element for delivering electrical energy to target tissue is mounted to the radially expandable element. The device can be constructed and arranged to ablate the duodenal mucosa of a patient while avoiding damage to the duodenal adventitial tissue. Systems and methods of treating target tissue are also provided.
Owner:FRACTYL HEALTH INC

Application of DPP-4 inhibitor in preparation of medicine for preventing and / or treating digestive tract stenosis

The invention provides application of a DPP-4 inhibitor in preparation of a medicine for preventing and / or treating digestive tract stenosis, and belongs to the technical field of medicine. On the basis of morphological manifestations of narrow-segment esophageal tissue adventitia scar fibrosis, obvious high expression of DPP-4 < + > fibroblast subgroups in narrow-segment esophageal adventitia fibrosis hyperplasia tissues is found. The DPP-4 inhibitor can be used for preventing and treating intractable stenosis after the esophageal ESD operation through anti-inflammatory and anti-fibrosis effects on esophageal outer tissues of a narrow section, and is a powerful supplement for the stenosis after the esophageal ESD operation focusing on intracavity prevention and treatment of esophageal submucosa and part of innate muscular scar fibrosis at present.
Owner:ZHANGJIANG INST OF SCI & TECH FUDAN UNIV PUDONG SHANGHAI +1

Combined artificial vascular sheath capable of reconstructing lymph node motive force, guiding device, and use method

PCT designated stageWO2026025518A1Blood vesselsVascular bundleHuman body
Disclosed are a combined artificial vascular sheath capable of reconstructing lymph node motive force, a guiding device, and a use method. The combined artificial vascular sheath comprises an elastic sheet and a plurality of tying bands connected to the elastic sheet, wherein the elastic sheet covers a vascular bundle, and the plurality of tying bands sequentially surround and bundle the vascular bundle to form a combined artificial vascular sheath wrapping the vascular bundle. The guiding device comprises a retractor, wherein the retractor is of an arc-shaped plate structure, the front end of the retractor is provided with a guide hook, and the guide hook matches a hook hole on the tying band and the opening thereof faces backwards. According to the present invention, the combined artificial vascular sheath with low elasticity is arranged on the surface of the vascular bundle to replace the damaged or hardened vascular adventitia which has lost its function, such that the function of squeezing and stimulating the peripheral lymph nodes of the blood vessel is reconstructed, and the influence on blood vessel branches is also reduced. The guiding device enables operators to conveniently implant the combined artificial vascular sheath, and has the advantages of simple structure, convenient operation and little damage to human bodies.
Owner:SHINEYARD MEDICAL DEVICE CO LTD

Apparatus for effective ablation and nerve sensing associated with denervation

An intravascular catheter for nerve activity ablation and / or sensing includes one or more needles advanced through supported guide tubes (needle guiding elements) which expand to contact the interior surface of the wall of the renal artery or other vessel of a human body allowing the needles to be advanced though the vessel wall into the extra-luminal tissue including the media, adventitia and periadvential space. The catheter also includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened needles are advanced to penetrate into the vessel wall. Electrodes near the distal ends of the needles allow sensing of nerve activity before and after attempted renal denervation. In a combination embodiment ablative energy or fluid is delivered from the needles in or near the adventitia to ablate nerves outside of the media while sparing nerves within the media.
Owner:ABLATIVE SOLUTIONS INC

Cardiovascular surgical devices, systems, and methods

A robotic surgical method for repair of an infrarenal aortic aneurysm with an aneurysm sac in an aorta of a patient includes introducing at least one arm and a camera of a robotic surgical system into designated ports of the patient. Then, a graft is attached to a proximal wall of the aorta. The aneurysm sac is decompressed by inflating an intravascular balloon and initiating flow in an arteriovenous circuit. Anterior posterior walls of the aneurysm sac are stapled and the robotic incisions are closed. A method for inserting a conduit includes deploying an intimal umbrella, partially expanding an expandable graft, deploying an adventitial umbrella, and fully inflating the expandable stent.
Owner:BASSIOUNY HISHAM

Novel balloon catheter and method for expanding occluded section of blood vessel

According to the novel balloon catheter and the method for expanding the blood vessel blocked segment, balloons comprise the first balloon and the second balloon, the cross section of each balloon is in a gourd shape defined by two semi-circular rings, the first balloon is provided with a guide wire cavity, the balloon is a filling cavity except the guide wire cavity, and the second balloon is used for expanding the blood vessel wall outwards in the blood vessel blocked segment; a balloon filling cavity is formed between the inner tube and the outer tube, a filling cavity of the balloon is communicated with the balloon filling cavity, and an inner cavity of the inner tube is communicated with a guide wire cavity of the balloon. After the covered stent is implanted into a blood vessel occlusion section, the balloon is pushed into the covered stent, the second balloon faces the blood vessel wall side, and the filling material is injected into the balloon after the second balloon is in place. The second balloon can be ejected out from the covered stent to the outer side of the blood vessel wall, so that the outer membrane of the blood vessel and part of the outer-side intima of the blood vessel are broken, the covered stent obtains a space to bulge out of the blood vessel, the diameter of the implanted covered stent is increased, and then the balloon is withdrawn, so that blood flow can smoothly flow through the covered stent, and the interior of the covered stent is prevented from being blocked after an operation.
Owner:郭亦帆

Use of a dpp-4 inhibitor for the preparation of a medicament for the prevention and / or treatment of a stricture of the digestive tract

The application provides application of a DPP-4 inhibitor in preparation of a medicine for preventing and / or treating digestive tract stenosis, and belongs to the technical field of medicines. Based on morphological performance of stenosis segment esophageal tissue outer membrane scar fibrosis, it is found that a DPP-4+ fibroblast subpopulation in stenosis segment esophageal outer membrane fibrosis hyperplasia tissue is obviously highly expressed. The DPP-4 inhibitor can prevent and treat refractory stenosis after esophageal ESD operation through anti-inflammatory and anti-fibrosis effects on stenosis segment esophageal outer layer tissue, and is a powerful supplement to the current esophageal ESD postoperative stenosis which focuses on intraluminal prevention and treatment of esophageal submucosa and part of inherent muscle layer scar fibrosis.
Owner:ZHANGJIANG INST OF SCI & TECH FUDAN UNIV PUDONG SHANGHAI +1

Tracheal dilation device and its preparation method

Embodiments of the present disclosure provide a tracheal dilation device and a preparation method thereof. The device includes: a body having a C-shaped structure, the body being provided with a hole; a pulling wire, one end of which passes through and is fixed in the hole; wherein the body is configured to be disposed around the outer periphery of the trachea, and the other end of the pulling wire is fixed to the adventitia of the trachea, and the body applies an outward expanding traction force to the adventitia of the trachea via the pulling wire. The tracheal dilation device and the preparation method thereof provided by the embodiments of the present disclosure can fix the body to the outer periphery of the trachea and surround the trachea via the pulling wire, and one end of the pulling wire is fixed to the adventitia of the trachea, and the other end passes through and is fixed in the hole, so that the body can apply an outward expanding traction force to the trachea via the pulling wire, realizing the outward expansion and fixation of the trachea. Since one end of the pulling wire is fixed to the adventitia of the trachea, the inner diameter of the trachea can be increased without damaging the inner membrane of the trachea, realizing the expansion of the trachea.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

A method for constructing an animal model of cardiomyopathy induced by circulatory system and application thereof

This invention relates to the field of medical animal model construction technology, and in particular to a method for constructing an animal model of cardiomyopathy induced by the circulatory system and its application. This invention, through adventitia-35 injection, establishes for the first time an animal model of "Aβ25-35-induced cardiomyopathy via the adventitia-35 circulatory system" in SD rats. In this model, Aβ25-35 perfusion via the adventitia-35 myocardium of the lower limbs induces diffuse myocardial fibrosis and a decrease in ejection fraction in SD rats, consistent with epidemiological data. This model can be used to further study the pathogenic mechanism of Aβ25-35-induced cardiomyopathy and novel treatment methods using adventitia-35 transport as a pathway, while also providing a new perspective for studying the pathogenic mechanisms and diagnostic and treatment methods of AD or cerebrovascular diseases.
Owner:BEIJING HOSPITAL

Ablation systems, devices and methods for the treatment of tissue

A device for ablating target tissue of a patient with an ablative fluid is provided. An elongate shaft includes a proximal portion and a distal portion, and at least one fluid delivery element is attached to the distal portion. The device can be configured to ablate the duodenal mucosa of a patient while avoiding damage to the duodenal adventitial tissue. Systems and methods of treating target tissue are also provided.
Owner:FRACTYL HEALTH INC

Electrical energy ablation systems, devices and methods for the treatment of tissue

ActiveUS20250295444A1EndoscopesMedical devicesSurgeryDuodenal mucous membrane
A device for ablating target tissue of a patient with electrical energy is provided. An elongate shaft includes a proximal portion and a distal portion, and a radially expandable element is attached to the distal portion. An ablation element for delivering electrical energy to target tissue is mounted to the radially expandable element. The device can be constructed and arranged to ablate the duodenal mucosa of a patient while avoiding damage to the duodenal adventitial tissue. Systems and methods of treating target tissue are also provided.
Owner:FRACTYL HEALTH INC

Aorta cannula

The utility model discloses an aortic cannula, and relates to the technical field of aortic cannulas. Comprising a cannula body, a first positioning airbag, a second positioning airbag and a connecting hose. The first positioning air bag and the second positioning air bag are arranged on the outer side of the cannula body and can be tightly pressed on the inner side and the outer side of an aorta adventitia respectively during use, and the problems that high-pressure blood flow enters an aorta cavity, and aorta dissection or false aneurysm is formed are solved; meanwhile, when the intubation tube body needs to be separated from extracorporeal circulation for tube drawing operation, air in the second positioning air bag is completely discharged, then the intubation tube body is pulled out, the first positioning air bag can play a role in blocking sprayed blood flow, and the operator can be effectively protected; the problems that in a traditional aortic cannula, the aortic wall structure is prone to being damaged in the cannula inserting process, and false aneurysm or aortic dissection is formed are solved; the blood pressure in the aorta blood vessel is high, the purse string is easy to avulsion, the aorta wall is damaged, and the intubation tube is easy to fall off.
Owner:WUHAN ASIA HEART HOSPITAL

Newborn umbilical inflammation infection risk early warning method combining umbilical secretions with ultrasound

ActiveCN121601250BImage enhancementImage analysisUmbilical inflammationWhite blood cell
The present application relates to the technical field of health risk assessment, in particular to a new-born umbilical inflammation infection risk early warning method combining umbilical secretions and ultrasound, which comprises: obtaining a target color reaction image corresponding to umbilical secretions of a new-born to be detected, and obtaining a transverse image, a sagittal image and a coronal image corresponding to the umbilical part of the new-born to be detected; analyzing the distribution of leukocyte released protease based on the target color reaction image; determining a blood vessel wall stratification index corresponding to each preset direction according to the thickness difference of the media region and the adventitia region in each preset direction; performing infection spread analysis on the sagittal image and the coronal image; and determining an umbilical inflammation infection risk early warning auxiliary value corresponding to the new-born to be detected according to the esterase activity distribution index, the spread infiltration scale index and all blood vessel wall stratification indexes. The present application improves the rationality of setting the umbilical inflammation infection risk early warning auxiliary value by analyzing multiple images.
Owner:NORTHWEST WOMEN & CHILDREN HOSPITAL

Ablation systems, devices and methods for the treatment of tissue

A device for ablating target tissue of a patient with an ablative fluid is provided. An elongate shaft includes a proximal portion and a distal portion, and at least one fluid delivery element is attached to the distal portion. The device can be configured to ablate the duodenal mucosa of a patient while avoiding damage to the duodenal adventitial tissue. Systems and methods of treating target tissue are also provided.
Owner:FRACTYL HEALTH INC

SIS-loaded polymer tubular structure artificial blood vessel and preparation method thereof

The invention discloses an SIS-loaded polymer tubular structure artificial blood vessel, and relates to the technical field of biomedical treatment, and the SIS-loaded polymer tubular structure artificial blood vessel comprises a polymer tubular structure which is prepared from a high polymer material through an electrostatic spinning or 3D printing process, the high polymer material is selected from at least one of polycaprolactone, polylactic acid, polyurethane, a polylactic acid-glycolic acid copolymer, poly (L-lactide-caprolactone) or poly (p-dioxanone); and the SIS layer is prepared by dissolving SIS powder in 0.1-1M acetic acid solution to prepare a 1%-10% solution. The invention relates to a preparation method of an SIS-loaded polymer tubular structure artificial blood vessel. The preparation method comprises the following steps: preparing SIS: cleaning and segmenting fresh small intestine and jejunum, and scraping an outer membrane, a muscular layer and an inner mucosa; according to the invention, a physical perfusion-freeze drying method is innovatively adopted to realize efficient loading of SIS; and more than 95% of active factors in the SIS are reserved through a gradient decellularization process.
Owner:LINGBO BIOTECHNOLOGY (HANGZHOU) CO LTD

Nerve conduit

PendingCN121003508AProsthesisNerve tractTerminal nerve
The invention provides a nerve conduit, which comprises a cannula, one end of the cannula is provided with an opening, and the other end of the cannula is provided with a folding part; the shape of the filling block is matched with the internal shape of the sleeve; when the filling block is assembled in the sleeve, the distance between one end, close to the opening, of the filling block and one end of the opening of the sleeve is preset; wherein a plurality of through holes are formed in the side wall of the sleeve, and the through holes are configured to provide passages for permeation of tissue fluid; and the filling block is made of a degradable biomedical material. According to the nerve conduit provided by the invention, a protective envelope is formed through the sleeve, replaces an adventitia, coats and limits the growth of nerve tracts, and nerves can be subjected to the action of relative mechanical stress along with the narrowing of the surrounding growth environment, so that the formation of neuroma is more quickly and stably prevented, the extrusion of surrounding muscles in a body is resisted, and the terminal nerves are protected. The nerve conduit is simple in structure and has good mechanical properties, and industrial mass production can be achieved.
Owner:BEIJING BIOSIS HEALING BIOLOGICAL TECH CO LTD

Three-dimensional imaging of coronary arteries

A method for three-dimensional (3D) imaging of coronary arteries includes acquiring a sequence of two-dimensional (2D) intravascular (IV) images of a coronary artery, extracting a set of IV longitudinal images from the sequence of IV images, detecting a lumen border of the coronary artery and a media-adventitia (MA) border of the coronary artery based on the set of IV longitudinal images, estimating a sequence of geometric mass centers based on the lumen border and the MA border, estimating a 2D motion signal from the sequence of geometric mass centers, estimating a sequence of rotations for the sequence of 2D IV images based on the 2D motion signal, generating a sequence of transformed IV frames from the sequence of 2D IV images based on the sequence of rotations and the 2D motion signal, and reconstructing a 3D image from the sequence of transformed IV frames.
Owner:KERMANI ALI

Nerve conduit

PendingCN121196790AProsthesisNerve tractTerminal nerve
The invention provides a nerve conduit, which comprises a sleeve, one end of the sleeve is provided with an opening, and the other end of the sleeve is provided with a fixing part; the supporting frame comprises one or more supporting plates; when the supporting frame is assembled in the sleeve, the interior of the sleeve is divided into a plurality of axial limiting channels by the supporting plates, and the limiting channels are configured to provide a preset growth path; a plurality of through holes are formed in the side wall of the sleeve, and the through holes are configured to provide passages for permeation of tissue fluid. According to the nerve conduit provided by the invention, a protective envelope is formed through the sleeve, replaces an adventitia, coats and limits the growth of nerve tracts, and nerves can be subjected to the action of relative mechanical stress along with the narrowing of the surrounding growth environment, so that the formation of neuroma is more quickly and stably prevented, the extrusion of surrounding muscles in a body is resisted, and the terminal nerves are protected. The nerve conduit is simple in structure and has good mechanical properties, and industrial mass production can be achieved.
Owner:BEIJING BIOSIS HEALING BIOLOGICAL TECH CO LTD

Preparation method of human umbilical artery stem cell induced vascular organoid

The invention discloses a preparation method of human umbilical artery stem cell induced vascular organoid, and belongs to the field of biomedical engineering. The method aims to solve the problems of limited cell source, low induction efficiency, incomplete structure function and the like in the existing vascular organ preparation. The method comprises the following steps: separating and culturing human umbilical artery adventitia stem cells, taking the third to fifth generation cells, inducing the third to fifth generation cells for 5 days through an induction culture medium containing VEGF-A, FGF-2, CHIR99021, BMP4, Y27632 and Frosklin, mixing the cell aggregate with Matrigel-Collagen I to construct a three-dimensional system, and culturing the three-dimensional system with a mature culture medium containing VEGF-A and FGF-2 for 10 days to form vascular organs. According to the method, the human umbilical artery adventitia stem cells which are rich in source and free of ethical dispute are adopted, the induction efficiency is remarkably improved through staged induction and optimized factor combination, formed vascular organs are complete in lumen, rich in branch, stable in function, easy and convenient to operate and easy to standardize, and the method can be applied to the fields of cardiovascular disease research, drug screening and regenerative medicine.
Owner:安胜军

Methods and apparatuses for delivering an agent through VASA vasorum of a vessel

Described herein are methods and apparatuses (e.g., devices, systems, etc.) that may be used to deliver one or more agents (e.g., compounds, compositions, etc. including drugs, biologics, cells, etc.) to a target tissue in or adjacent to an adventitia through the vasa vasorum of a vessel. These methods and apparatuses may be used to deliver relatively large agents to a target tissue in or adjacent to an adventitia specifically through the vasa vasorum of arteries or veins.
Owner:RENOVORX INC

Systems and methods for modulating nerves or other tissue

According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) or other tissue are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves surrounding (e.g., within adventitia of or within perivascular space of) an artery or other blood vessel, such as the common hepatic artery.
Owner:MEDTRONIC IRELAND MFG UNLIMITED CO